Literature DB >> 17978907

The role of sildenafil citrate in the protection of gastric mucosa from nonsteroidal anti-inflammatory drug-induced damage.

Bülent Aydinli1, Mehmet Ilhan Yildirgan, Gürkan Oztürk, Sabri Selçuk Atamanalap, Kamil Yalçin Polat, Mahmut Başoğlu, Cemal Gündoğdu, Halis Süleyman, Ahmet Kiziltunç, Nesrin Gürsan, Durkaya Oren.   

Abstract

BACKGROUND: To investigate the protective effects of sildenafil citrate (SC) on indomethacin-induced gastric ulcer in a rat model.
METHODS: Gastric ulcers were induced by oral ingestion of indomethacin. Thirty rats were used in the study. The rats were divided into 3 groups, and given either SC (n=10) at a dose of 50 mg/kg or omeprazole (n=10), or no treatment (n=10, the control group). In addition to the measurements of ulceration areas, the sum of gastric tissue nitrite (NO2-) and nitrate (NO3-) were evaluated as an indicator of gastric tissue NO level. All the measurements were done at 6th hour of oral administration of indomethacin.
RESULTS: The mean values of ulceration areas were 4.0+/-2.31, 3.0+/-2.00, and 21.4+/-8.43 in the SC, omeprazole and control groups, respectively. The mean values of ulceration areas in the SC-treated group was lower than that of the control group. The contents of NO were 32.2+/-3.05, 24.8+/-3.23 and 21.0+/-0.82 (micromol/g protein) in gastric tissue in indomethacin, SC, omeprazole and control groups, respectively, The content of NO in the SC-treated groups was significantly higher than control group (p<0.001).
CONCLUSION: Sildenafil citrate may have a role in protecting gastric mucosa from the damage caused by indomethacin. This effect may be associated with the increased level of NO in gastric tissue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17978907

Source DB:  PubMed          Journal:  Ulus Travma Acil Cerrahi Derg


  2 in total

1.  The potential beneficial effects of sildenafil and diosmin in experimentally-induced gastric ulcer in rats.

Authors:  Alaa E El-Sisi; Samia S Sokar; Sally E Abu-Risha; Doaa Y Khira
Journal:  Heliyon       Date:  2020-08-22

2.  Mitigation of indomethacin-induced gastric mucosal lesions by a potent specific type V phosphodiesterase inhibitor.

Authors:  Kemal Karakaya; Volkan Hanci; Sibel Bektas; Murat Can; Hamdi-B Ucan; Ali-Ugur Emre; Oge Tascilar; Isil Ozkocak Turan; Mustafa Comert; Oktay Irkorucu; Guldeniz Karadeniz Cakmak
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.